Elucidating the phase 1 trial experience among study participants following completion of the INTERCEPT-AD study of sabirnetug (ACU193) for early Alzheimer's disease: a qualitative interview study.
Saved in:
| Title: | Elucidating the phase 1 trial experience among study participants following completion of the INTERCEPT-AD study of sabirnetug (ACU193) for early Alzheimer's disease: a qualitative interview study. |
|---|---|
| Authors: | Merikle E; Clinical Outcomes Assessment Consultant, Parksville, BC, Canada., Presnall C; Independent Researcher, Tucson, AZ, USA., Feaster T; Acumen Pharmaceuticals, Inc, Newton, MA, USA., Moxon R; Acumen Pharmaceuticals, Inc, Newton, MA, USA., Siemers E; Acumen Pharmaceuticals, Inc, Newton, MA, USA., Kerwin D; Kerwin Medical Center, Dallas, TX, USA., Cline S; Acumen Pharmaceuticals, Inc, Newton, MA, USA. scline@acumenpharm.com. |
| Source: | Trials [Trials] 2026 Mar 23; Vol. 27 (1). Date of Electronic Publication: 2026 Mar 23. |
| Publication Type: | Journal Article; Clinical Trial, Phase I |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215 (Electronic) Linking ISSN: 17456215 NLM ISO Abbreviation: Trials Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41872889 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Elucidating the phase 1 trial experience among study participants following completion of the INTERCEPT-AD study of sabirnetug (ACU193) for early Alzheimer's disease: a qualitative interview study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Merikle+E%22">Merikle E</searchLink>; Clinical Outcomes Assessment Consultant, Parksville, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Presnall+C%22">Presnall C</searchLink>; Independent Researcher, Tucson, AZ, USA.<br /><searchLink fieldCode="AU" term="%22Feaster+T%22">Feaster T</searchLink>; Acumen Pharmaceuticals, Inc, Newton, MA, USA.<br /><searchLink fieldCode="AU" term="%22Moxon+R%22">Moxon R</searchLink>; Acumen Pharmaceuticals, Inc, Newton, MA, USA.<br /><searchLink fieldCode="AU" term="%22Siemers+E%22">Siemers E</searchLink>; Acumen Pharmaceuticals, Inc, Newton, MA, USA.<br /><searchLink fieldCode="AU" term="%22Kerwin+D%22">Kerwin D</searchLink>; Kerwin Medical Center, Dallas, TX, USA.<br /><searchLink fieldCode="AU" term="%22Cline+S%22">Cline S</searchLink>; Acumen Pharmaceuticals, Inc, Newton, MA, USA. scline@acumenpharm.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101263253%22">Trials</searchLink> [Trials] 2026 Mar 23; Vol. 27 (1). <i>Date of Electronic Publication: </i>2026 Mar 23. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Clinical Trial, Phase I – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101263253 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1745-6215 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217456215%22">17456215 </searchLink><i>NLM ISO Abbreviation: </i>Trials <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41872889 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s13063-026-09656-w Languages: – Code: eng Text: English Titles: – TitleFull: Elucidating the phase 1 trial experience among study participants following completion of the INTERCEPT-AD study of sabirnetug (ACU193) for early Alzheimer's disease: a qualitative interview study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Merikle E – PersonEntity: Name: NameFull: Presnall C – PersonEntity: Name: NameFull: Feaster T – PersonEntity: Name: NameFull: Moxon R – PersonEntity: Name: NameFull: Siemers E – PersonEntity: Name: NameFull: Kerwin D – PersonEntity: Name: NameFull: Cline S IsPartOfRelationships: – BibEntity: Dates: – D: 23 M: 03 Text: 2026 Mar 23 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1745-6215 Numbering: – Type: volume Value: 27 – Type: issue Value: 1 Titles: – TitleFull: Trials Type: main |
| ResultId | 1 |
